Results 191 to 200 of about 15,943 (285)

Aborted sudden cardiac event in pediatric restrictive cardiomyopathy: When ST changes on ambulatory monitoring matter. [PDF]

HeartRhythm Case Rep
Christmas A, Nasman C, Boyle G, Patel A, Aziz P, El Assaad I.   +5 more
europepmc   +1 more source

Restrictive Cardiomyopathy in Childhood: Case Report

, 2013
Osman Guvenc
openalex   +1 more source

Differentiation Between Restrictive Cardiomyopathy and Constrictive Pericarditis by Early Diastolic Doppler Myocardial Velocity Gradient at the Posterior Wall [PDF]

, 2000
Przemysław Palka, Aleksandra Lange, J.Elisabeth Donnelly, Petros Nihoyannopoulos   +3 more
openalex   +1 more source

ADAM17 and its proteolytic targets in disease pathogenesis

The FEBS Journal, EarlyView.
ADAM17 as a multifunctional sheddase with contrasting roles across inflammatory, metabolic, cardiovascular, and neoplastic diseases. Through regulated activation by iRhom, iTAP/FRMD8, and tetraspanins, ADAM17 cleaves diverse membrane ligands and receptors, thereby promoting inflammation, fibrosis, obesity, insulin resistance, and tumor progression ...
Abdulbasit Amin, Marina Badenes
wiley   +1 more source

cTnIR193H restrictive cardiomyopathy mice satisfy high-energy metabolic demands through regulating glucose metabolism. [PDF]

Genes Dis
Luo M, Liu L, Yuan W, Quan J, Li M, Tian J.   +5 more
europepmc   +1 more source

Hemodynamic Consequences and Clinical Outcomes With Intravenous Lidocaine Infusion in Patients With Atrial Fibrillation

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Intravenous lidocaine is frequently used for refractory ventricular arrhythmia (VA). Atrial fibrillation (AF) is a common comorbidity in VA patients. Lidocaine poses theoretical risks of hemodynamic compromise and pro‐arrhythmia, including AF with rapid ventricular rates (RVR).
Andrea N. Keithler, Zameer Abedin, Deborah Furman, Luke Schwarz, Marc C. Engels, Roger A. Freedman, Klitos Konstantinidis, H. Immo Lehmann, Ravi Ranjan, Benjamin A. Steinberg, T. Jared Bunch   +10 more
wiley   +1 more source

The MYH7 c.2770G > A (p.Glu924Lys) mutation exhibits phenotypic heterogeneity in hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM): a case report. [PDF]

BMC Cardiovasc Disord
Han Y, Wang H, Zhang H, Wang M, Gan L, Meng F.   +5 more
europepmc   +1 more source

Association of glucagon‐like peptide‐1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
This TriNetX (US, 2016–2023) study compared clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes treated with GLP‐1 receptor agonists vs DPP4 inhibitors. ABSTRACT Objectives To evaluate whether glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are associated with improved survival and renal outcomes in patients with ...
Yu‐Ting Yu, Ying Chun Lee, Yu‐Wei Fang, Wen‐Hui Hsieh, Ming‐Hsien Tsai   +4 more
wiley   +1 more source

Prognostic implications of multiple chamber longitudinal strains and myocardial work in restrictive cardiomyopathy. [PDF]

Sci Rep
Li X, Liu X, Feng X, Guo T, Liu G, Wu D, Liu Y, Lai J, Liu Y, Lin X, Fang L, Chen W.   +11 more
europepmc   +1 more source

Barriers and Facilitators to Early Postpartum Blood Pressure Follow‐Up After Hypertensive Disorders of Pregnancy: An Integrative Review

Journal of Midwifery &Women's Health, EarlyView.
Introduction Hypertensive disorders of pregnancy (HDP) are a leading cause of preventable maternal morbidity and mortality in the United States. Because blood pressure (BP) often peaks after hospital discharge, clinical guidelines recommend BP evaluation within 7 to 10 days postpartum. Yet fewer than half of postpartum individuals with HDP receive this
Jill C. Doyle, Christopher S. Lee, Lucinda Canty   +2 more
wiley   +1 more source